Brian M Hoff

715 total citations
18 papers, 546 citations indexed

About

Brian M Hoff is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Brian M Hoff has authored 18 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Applied Microbiology and Biotechnology, 8 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Brian M Hoff's work include Antibiotic Use and Resistance (10 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Pneumonia and Respiratory Infections (4 papers). Brian M Hoff is often cited by papers focused on Antibiotic Use and Resistance (10 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Pneumonia and Respiratory Infections (4 papers). Brian M Hoff collaborates with scholars based in United States, Canada and United Kingdom. Brian M Hoff's co-authors include Karen Marchillo, Jeniel E. Nett, Kathleen A. Holoyda, Randall J. Massey, David R. Andes, William E. Dager, Brett H. Heintz, Stephen W. Zimmerman, Michihiko Goto and Chao Qi and has published in prestigious journals such as The American Journal of Medicine, Antimicrobial Agents and Chemotherapy and Infection Control and Hospital Epidemiology.

In The Last Decade

Brian M Hoff

16 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian M Hoff United States 7 301 191 160 102 61 18 546
Carla Walraven United States 13 447 1.5× 244 1.3× 108 0.7× 75 0.7× 41 0.7× 26 567
Ali Hassoun United States 10 449 1.5× 208 1.1× 214 1.3× 76 0.7× 37 0.6× 42 784
I.M. Gould United Kingdom 14 317 1.1× 271 1.4× 72 0.5× 67 0.7× 55 0.9× 30 651
Evelien Oostdijk Netherlands 14 226 0.8× 176 0.9× 166 1.0× 47 0.5× 116 1.9× 19 694
Wafa Achour Tunisia 15 180 0.6× 189 1.0× 174 1.1× 71 0.7× 61 1.0× 79 767
João Paulo Telles Brazil 14 265 0.9× 138 0.7× 155 1.0× 101 1.0× 95 1.6× 53 661
Emanuela Sozio Italy 15 275 0.9× 181 0.9× 87 0.5× 76 0.7× 80 1.3× 41 619
Guilherme Henrique Campos Furtado Brazil 17 227 0.8× 201 1.1× 70 0.4× 153 1.5× 136 2.2× 40 652
Daisuke Sakanashi Japan 17 287 1.0× 368 1.9× 103 0.6× 110 1.1× 80 1.3× 86 873
C. Muller France 9 188 0.6× 146 0.8× 47 0.3× 64 0.6× 103 1.7× 10 523

Countries citing papers authored by Brian M Hoff

Since Specialization
Citations

This map shows the geographic impact of Brian M Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M Hoff more than expected).

Fields of papers citing papers by Brian M Hoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M Hoff. The network helps show where Brian M Hoff may publish in the future.

Co-authorship network of co-authors of Brian M Hoff

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M Hoff. A scholar is included among the top collaborators of Brian M Hoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M Hoff. Brian M Hoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Santarossa, Maressa, et al.. (2023). 2585. Identification of Risk Factors for Pseudomonas aeruginosa in Patients with Community-Acquired Pneumonia. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
2.
Chang, Ke‐Vin, et al.. (2023). Antimicrobial Stewardship Techniques for Critically Ill Patients with Pneumonia. Antibiotics. 12(2). 295–295. 6 indexed citations
3.
Hoff, Brian M, et al.. (2023). Evaluation of Microbiological Concordance of a Rapid Molecular Diagnostic Pneumonia Panel in a Real-World Population with Pneumonia. The Journal of Applied Laboratory Medicine. 8(3). 514–522. 6 indexed citations
4.
Hoff, Brian M, William J Moore, Michael Postelnick, et al.. (2022). 180. Impact of a two-step diagnostic bundle on hospital-onset Clostridioides difficile infection rates and treatment across a large health system.. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations
5.
6.
7.
O’Donnell, J. Nicholas, Nathaniel J. Rhodes, Teresa Zembower, et al.. (2021). Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study. International Journal of Antimicrobial Agents. 59(2). 106490–106490. 3 indexed citations
8.
Hoff, Brian M, et al.. (2021). Defining the Importance of Age-Related Changes in Drug Clearance to Optimizing Aminoglycoside Dosing Regimens for Adult Patients with Cystic Fibrosis. European Journal of Drug Metabolism and Pharmacokinetics. 47(2). 199–209. 3 indexed citations
9.
Hoff, Brian M, Marc H. Scheetz, Manu Jain, Joanne Cullina, & Nathaniel J. Rhodes. (2020). Exploring the Relationship between FEV1 Loss and Recovery and Aminoglycoside Pharmacokinetics in Adult Patients with Cystic Fibrosis: Implications for Clinical Dosing Strategies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(6). 584–591. 1 indexed citations
10.
Martin, David W., Amanda K. Gibson, Brian M Hoff, et al.. (2019). Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study. Infection Control and Hospital Epidemiology. 40(3). 269–275. 31 indexed citations
11.
Hoff, Brian M, Sarah H. Sutton, Teresa Zembower, et al.. (2019). 2010. A Significant Reduction in Empiric Vancomycin Days of Therapy for Suspected MRSA Pneumonia in Adult Non-ICU Patients After Implementation of a Rapid MRSA Nasal PCR Test with Antimicrobial Stewardship Intervention. Open Forum Infectious Diseases. 6(Supplement_2). S674–S675. 1 indexed citations
13.
Suda, Katie J., Daniel J. Livorsi, Michihiko Goto, et al.. (2018). Research Agenda for Antimicrobial Stewardship in the Veterans Health Administration. Infection Control and Hospital Epidemiology. 39(2). 196–201. 9 indexed citations
14.
Rogers, William K., et al.. (2018). Implementation of a multifaceted program to sustainably improve appropriate intraoperative antibiotic redosing. American Journal of Infection Control. 47(1). 74–77. 15 indexed citations
15.
Hoff, Brian M, Dilek İnce, Erika J. Ernst, et al.. (2018). Implementation of a Mobile Clinical Decision Support Application to Augment Local Antimicrobial Stewardship. Journal of Pathology Informatics. 9(1). 10–10. 19 indexed citations
16.
Chung, Jina, et al.. (2018). Patient perceptions of antibiotic use and resistance at a single university dermatology clinic. Journal of Dermatological Treatment. 30(1). 92–95. 3 indexed citations
17.
Nett, Jeniel E., Karen Marchillo, Randall J. Massey, et al.. (2006). Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance. Antimicrobial Agents and Chemotherapy. 51(2). 510–520. 312 indexed citations
18.
Zimmerman, Stephen W., et al.. (1979). Goodpasture's syndrome with normal renal function. The American Journal of Medicine. 66(1). 163–171. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026